Balanced news tone
News Sentiment
SIBN sentiment intelligence
Si-Bone Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
+2.6% over one week, +13.9% over four weeks, trend inactive, and near fair-value range.
Si-Bone SVP Michael Pisetsky sells $52,375 in stock
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Si-Bone SVP Michael Pisetsky sells $52,375 in stock
Michael Pisetsky, SVP at SI-BONE Inc., sold 3,134 shares totaling $52,375 on July 2, 2026. These sales were made to cover tax obligations from restricted stock units, not discretionary trading. Despite the sale, Pisetsky still holds a substantial number of shares, and the company
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 05:12
- Source
- Investing.com
SI-BONE (NASDAQ: SIBN) CFO sells shares to cover RSU tax withholding
SI-BONE, Inc. (NASDAQ: SIBN) CFO Anshul Maheshwari sold 3,317 shares of common stock on July 2, 2026, in a "sell to cover" transaction to fulfill tax withholding obligations related to the vesting of restricted stock units. The sales were executed at weighted average prices of $1
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 21:10
- Source
- Stock Titan
Form 4 Si-Bone Inc For: 6 July By Investing.com
This article from Investing.com reports on a Form 4 filing for Si-Bone Inc., detailing the filing made on July 6th. The content is brief, primarily serving as an announcement of the filing and includes a stock symbol reference for Si-Bone Inc. (SIBN).
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 21:10
- Source
- Investing.com Canada
SIBN - SI-BONE Inc Latest SEC Filings
This article provides detailed financial data and performance metrics for SI-BONE Inc (SIBN), including its latest stock price, market capitalization, earnings per share, sales, and various financial ratios. It also lists insider and institutional ownership, analyst recommendatio
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Jul 2026 19:09
- Source
- Finviz
Price to sales forward of SI-BONE, Inc. – NASDAQ:SIBN
The article displays the "Price to sales forward" metric for SI-BONE, Inc. (NASDAQ: SIBN). It appears to be a financial data snippet from TradingView, showing a specific period value and change percentages for this financial ratio. The broader content seems to be boilerplate info
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 06:10
- Source
- TradingView
Price to book forward of SI-BONE, Inc. – NASDAQ:SIBN
This article provides a brief financial overview for SI-BONE, Inc. (SIBN) on TradingView, specifically focusing on its forward price-to-book value. It indicates the market status as closed with no trades and originates from Nasdaq Stock Market data.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 02:41
- Source
- TradingView
SI-BONE, Inc. Actuals & Estimates (NASDAQ:SIBN)
This article provides an overview of SI-BONE, Inc. (NASDAQ:SIBN) stock performance, financial data, and analyst estimates. It highlights the current stock price, market capitalization, historical highs and lows, and future price forecasts from analysts. The report also details re
- Tone
- Positive 60/100
- Event
- Analyst action
- Published
- 26 Jun 2026 06:39
- Source
- TradingView
SI-BONE Inc. (SIBN) Attempts to Reclaim Ground After Recent Pullback - Factor Crowding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 21:44
- Source
- dars.gov.et
SI-BONE Inc. (SIBN) Attempts to Reclaim Ground After Recent Pullback - ETF Liquidity
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 25 Jun 2026 07:00
- Source
- DonanımHaber
SI-BONE outlines path to profitability, shares trade on Nasdaq in a volatile medtech sector
SI-BONE Inc., a medical device company specializing in minimally invasive implants for sacroiliac joint dysfunction, is working towards profitability amidst a competitive medtech landscape. Its shares trade on Nasdaq alongside larger peers, with analyst coverage focusing on reven
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 23 Jun 2026 16:27
- Source
- AD HOC NEWS
SI-BONE strategy focuses on differentiated sacropelvic implants, shares on Nasdaq in a competitive m
SI-BONE Inc. is a specialized medical device company listed on Nasdaq, focusing on minimally invasive sacropelvic joint fusion solutions. The company differentiates itself by concentrating on specific lower spine and pelvic conditions, offering implants and instruments for sacroi
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 22 Jun 2026 15:40
- Source
- AD HOC NEWS
SIBN Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for SI-BONE Inc (SIBN), based on various technical indicators and moving averages. As of June 18, 2026, the overall consensus for SIBN is a "Strong Buy" according to Intellectia's proprietary analysis, with a maj
- Tone
- Positive 75/100
- Event
- Guidance
- Published
- 21 Jun 2026 18:40
- Source
- Intellectia AI
SI-BONE Inc (SIBN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for SI-BONE Inc (SIBN), highlighting its business segments and regional contributions. As of June 17, SI-BONE Inc. had a market capitalization of $674.55 million. The company's revenue is primarily generated in the United States, accounti
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 01:40
- Source
- TradingKey
SI-BONE Inc (SIBN) Earnings Forecast: Future EPS & Revenue Growth Estimates
SI-BONE Inc (SIBN) currently has an earnings forecast score of 8.44 and an average price target of $25.00 from analysts, with a high of $32.00 and a low of $21.00. The consensus among 9 analysts is a "Buy" rating for the stock. The company's expected revenue for the next quarter
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 17 Jun 2026 22:40
- Source
- TradingKey
Precision Trading with Si-bone Inc. (SIBN) Risk Zones
This article provides a quantitative risk analysis for Si-bone Inc. (SIBN), highlighting a mid-channel oscillation pattern and a favorable 69.3:1 risk-reward setup. It outlines three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 17 Jun 2026 21:26
- Source
- Stock Traders Daily
SI-BONE Inc (SIBN) Shareholder Structure: Major Shareholders & Institutional Holdings
This article provides a detailed breakdown of SI-BONE Inc's (SIBN) shareholder structure, listing major shareholders by proportion and categorizing shareholder types. It also includes institutional shareholding trends over several quarters and recent shareholder activity, along w
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 18:40
- Source
- TradingKey
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 07:00
- Source
- Market source
SI-BONE extends headquarters lease and reports annual meeting voting results By Investing.com
SI-BONE, Inc. (NASDAQ:SIBN) announced the extension of its headquarters lease for one month, with an option for an additional month, and reported the results of its annual stockholders' meeting. Shareholders re-elected two directors, ratified the appointment of their independent
- Tone
- Positive 59/100
- Event
- Earnings
- Published
- 09 Jun 2026 22:09
- Source
- Investing.com South Africa
Technical Reactions to SIBN Trends in Macro Strategies
This article analyzes Si-bone Inc. (NASDAQ: SIBN) using AI models, identifying a positive near-term sentiment while broader alignment remains weak, characterized by a mid-channel oscillation pattern. It presents three distinct trading strategies (Position, Momentum Breakout, Risk
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 06 Jun 2026 19:56
- Source
- Stock Traders Daily
SI-BONE Inc. (SIBN) Edges Lower Amid Consolidation Near Key Support Levels - MA Cross Alert
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- DonanımHaber
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Analysts Have Been Trimming Their SI-BONE, Inc. (NASDAQ:SIBN) Price Target After Its Latest Report
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
SI-BONE Inc (SIBN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
- Tone
- Positive 84/100
- Event
- Guidance
- Published
- 12 May 2026 07:06
- Source
- GuruFocus.com
Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- StockStory
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory